TG Therapeutics director granted 8,325 stock units
Echelard Yann reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Echelard Yann reported acquisition or exercise transactions in this Form 4 filing.
TG Therapeutics director Yann Echelard received a grant of 8,325 stock tracking units as equity compensation. Each unit represents a contingent right to receive either one share of common stock or a cash payment equal to the fair market value of one share. The committee administering the company’s 2022 Incentive Plan will choose stock or cash, and settlement must occur within 30 days after the first anniversary of the grant date. The units vest on the first anniversary of grant if Echelard remains in continuous service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 8,325 shares
Grant/Award
1 txn
Insider
Echelard Yann
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Tracking Unit | 8,325 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Tracking Unit — 8,325 contracts (Direct)
Footnotes (2)
- F1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.
- F2. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.
Key Figures
Stock tracking units granted: 8,325 units
Transaction price per unit: $0.00
Underlying common shares: 8,325 shares
+2 more
5 metrics
Stock tracking units granted
8,325 units
Grant to director on 2026-06-11
Transaction price per unit
$0.00
Equity award, not open-market purchase
Underlying common shares
8,325 shares
Each unit tied to one common share
Vesting schedule
1-year cliff
Vests on first anniversary of grant
Settlement window
Within 30 days
After first anniversary of grant date
Key Terms
Stock Tracking Unit, contingent right, fair market value, 2022 Incentive Plan, +1 more
5 terms
Stock Tracking Unit financial
"Each stock tracking unit ("STU") represents a contingent right to receive either..."
contingent right financial
"represents a contingent right to receive either (determined at the sole discretion..."
fair market value financial
"a cash payment equal to the fair market value of one share of the Issuer's common stock..."
The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.
2022 Incentive Plan financial
"the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan..."
A 2022 incentive plan is a formal program adopted in 2022 that outlines how a company will reward employees, executives, or directors with cash, stock, or other benefits tied to performance or continued service. Investors care because these plans can change how much ownership exists (dilution), affect reported profits through compensation costs, and influence whether managers are motivated to increase long‑term value—think of it as the rules for a company’s bonus and stock‑award system.
vesting financial
"the STUs shall vest upon the first anniversary of the date of grant..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TG Therapeutics (TGTX) director Yann Echelard report on this Form 4?
Yann Echelard reported receiving 8,325 stock tracking units as an equity award. These units are linked to TG Therapeutics common stock and provide a contingent right to future stock or cash value, subject to vesting and plan terms.
How many stock tracking units did Yann Echelard receive from TG Therapeutics (TGTX)?
Echelard received 8,325 stock tracking units in this transaction. Each unit corresponds to a contingent right tied to one share of TG Therapeutics common stock, either in actual shares or an equivalent cash amount after the vesting period.
What is a stock tracking unit in the TG Therapeutics (TGTX) Form 4 filing?
Each stock tracking unit represents a contingent right to receive either one share of TG Therapeutics common stock or a cash payment equal to that share’s fair market value. The choice between stock and cash is made by the plan’s administering committee.
When do Yann Echelard’s TG Therapeutics (TGTX) stock tracking units vest and settle?
The stock tracking units vest on the first anniversary of the grant date, provided Echelard remains in continuous service with TG Therapeutics. Settlement in stock or cash must occur within 30 days after that first anniversary, under the plan’s terms.
Was Yann Echelard’s TG Therapeutics (TGTX) transaction an open-market buy or sell?
No, the transaction was a grant or award acquisition of 8,325 stock tracking units at a price of $0.00 per unit. It reflects equity compensation under the company’s 2022 Incentive Plan, not an open-market purchase or sale of shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
